… Address correspondence to Bevra H. Hahn, MD, University of California, Los Angeles,
School of Medicine, Room 32-48 Rehabilitation Building, Box 951670, Los Angeles, CA 90095-…

Background Oral contraceptives are rarely prescribed for women with systemic lupus
erythematosus, because of concern about potential negative side effects. In this double-blind, …

Background: There is concern that exogenous female hormones may worsen disease activity
in women with systemic lupus erythematosus (SLE). Objective: To evaluate the effect of …

Objective Women with systemic lupus erythematosus (SLE) have a 7–50‐fold increased risk
of coronary artery disease (CAD). In the general population, oxidized low‐density …

Objective To study 5 type I interferon (IFN)–inducible genes (LY6E, OAS1, OASL, MX1, and
ISG15) in patients with systemic lupus erythematosus (SLE) and to correlate expression …

miRNAs are small non-coding RNA molecules that modulate the expression of multiple
protein-encoding genes at the post-transcriptional level. They have recently been recognized as …

Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disease that predominantly
affects women. Previous findings that duplicated Toll-like receptor 7 (Tlr7) promotes lupus…

As patients with autoimmune rheumatic diseases live longer due to improved therapies and
preventive measures, death and disability from atherosclerosis, particularly myocardial …

Background Ustekinumab is a monoclonal antibody targeting interleukin (IL)-12 and IL-23
and is approved for the treatment of plaque psoriasis, psoriatic arthritis, and Crohn's disease. …

Causes of death were examined for 1,103 systemic lupus erythematosus patients who were
followed from 1965 to 1978 at 9 centers that participated in the Lupus Survival Study Group. …